Heterogeneity for integrin expression and cytokine‐mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins
暂无分享,去创建一个
[1] R. Supino,et al. Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive ability , 1990, International journal of cancer.
[2] R. Kramer,et al. Human microvascular endothelial cells use beta 1 and beta 3 integrin receptor complexes to attach to laminin , 1990, The Journal of cell biology.
[3] A. Sonnenberg,et al. The alpha 1/beta 1 and alpha 6/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin , 1990, The Journal of cell biology.
[4] E. Ruoslahti,et al. A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). , 1990, The Journal of biological chemistry.
[5] W. Carter,et al. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells , 1990, Journal of Cell Biology.
[6] H. Larjava,et al. Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells. , 1990, Cancer research.
[7] M. Elices,et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.
[8] A. Anichini,et al. Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinations , 1990 .
[9] S. Ferrone,et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. , 1990, Cancer research.
[10] J. Massagué,et al. Transforming growth factor-beta switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. , 1989, The Journal of biological chemistry.
[11] E. Ruoslahti,et al. Integrins and tumor cell dissemination. , 1989, Cancer cells.
[12] M. Elices,et al. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[13] W. Clark,et al. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. , 1989, Cancer research.
[14] C. Mueller-Eckhardt,et al. The Bra/Brb alloantigen system on human platelets. , 1989, Blood.
[15] A. Anichini,et al. Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. , 1989, Journal of immunology.
[16] M. Mareel,et al. Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin β3 and increased expression of c‐myc , 1989, International journal of cancer.
[17] Jeffrey W. Smith,et al. A novel vitronectin receptor integrin (α v β x ) is responsible for distinct adhesive properties of carcinoma cells , 1989, Cell.
[18] J. A. Mourik,et al. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex , 1989 .
[19] V. Quaranta,et al. A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. , 1989, The EMBO journal.
[20] S. Dedhar. Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin‐1β in human osteosarcoma cells: Inhibition of cell proliferation and stimulation of alkaline phosphatase activity , 1989, Journal of cellular physiology.
[21] R. Hynes,et al. Changes in integrin receptors on oncogenically transformed cells , 1989, Cell.
[22] L. Liotta,et al. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. , 1988, Journal of the National Cancer Institute.
[23] T. Springer,et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells , 1988, Nature.
[24] W. Carter,et al. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits , 1987, The Journal of cell biology.
[25] A. Anichini,et al. Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γ , 1986, International journal of cancer.
[26] M. Horton,et al. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. , 1985, Cancer research.
[27] N. Hogg,et al. Monoclonal antibodies specific for platelet glycoproteins react with human monocytes. , 1984, Blood.
[28] P. Lansdorp,et al. Monoclonal antibodies against human platelet glycoprotein IIIa , 1983, British journal of haematology.
[29] S. Ferrone,et al. Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies. , 1982, Clinical chemistry.
[30] R. Accolla,et al. Distinct forms of both alpha and beta subunits are present in the human Ia molecular pool. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Hemler. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. , 1990, Annual review of immunology.
[32] J. V. van Mourik,et al. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. , 1989, Blood.
[33] M. Herlyn,et al. Melanoma antigens: immunological and biological characterization and clinical significance. , 1988, Annual review of immunology.
[34] H. Strander. Interferon treatment of human neoplasia. , 1986, Advances in cancer research.
[35] L. Liotta. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.
[36] L. Liotta,et al. Laminin receptor on human breast carcinoma cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.